UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (46), p.19997-20002

2010

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban, a factor Xa inhibitor, induces the secondary prevention of cardiovascular events after myocardial ischemia reperfusion injury in mice

International journal of cardiology, 2016-10, Vol.220, p.602-607

2016

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes

Diabetes (New York, N.Y.), 2010-12, Vol.59 (12), p.3223-3228

2010

Link zum Volltext

Verfügbarkeit prüfen

HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer

Molecular cancer therapeutics, 2012-06, Vol.11 (6), p.1311-1319

2012

Link zum Volltext

Verfügbarkeit prüfen

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]

Journal of lipid research, 2011-06, Vol.52 (6), p.1200-1210

2011

Link zum Volltext

Verfügbarkeit prüfen

Recent progress in molecular mechanisms of angiotensin II type 1 and 2 receptors

Current pharmaceutical design, 2013, Vol.19 (17), p.2981

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor

The Journal of biological chemistry, 2006-07, Vol.281 (28), p.19288-19295

2006

Link zum Volltext

Verfügbarkeit prüfen

Chymase inhibitors

Current pharmaceutical design, 2013, Vol.19 (17), p.3065

2013

Link zum Volltext

Verfügbarkeit prüfen

Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins

Circulation Journal, 2011, Vol.75(7), pp.1533-1538

2011

Link zum Volltext

Verfügbarkeit prüfen

Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo

International journal of cardiology, 2015-08, Vol.192, p.82-88

2015

Link zum Volltext

Verfügbarkeit prüfen

Differential Bonding Interactions of Inverse Agonists of Angiotensin II Type 1 Receptor in Stabilizing the Inactive State

Molecular endocrinology (Baltimore, Md.), 2008-01, Vol.22 (1), p.139-146

2008

Link zum Volltext

Verfügbarkeit prüfen

FAMP, a Novel ApoA‐I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE‐Deficient Mice

Journal of the American Heart Association, 2013-06, Vol.2 (3), p.e000048-n/a

2013

Link zum Volltext

Verfügbarkeit prüfen

The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway

International journal of cardiology, 2016-03, Vol.207, p.317-325

2016

Link zum Volltext

Verfügbarkeit prüfen

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways

Integrative biology (Cambridge), 2011-04, Vol.3 (4), p.479-489

2011

Link zum Volltext

Verfügbarkeit prüfen

Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects

International Heart Journal, 2015, Vol.56(6), pp.656-660

2015

Link zum Volltext

Verfügbarkeit prüfen

Antiarrhythmogenic Effect of Reconstituted High-Density Lipoprotein Against Ischemia/Reperfusion in Rats

Journal of the American College of Cardiology, 2008-04, Vol.51 (16), p.1604-1612

2008

Link zum Volltext

Verfügbarkeit prüfen

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma

Journal of lipid research, 2011-10, Vol.52 (10), p.1795-1809

2011

Link zum Volltext

Verfügbarkeit prüfen

L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice

Drug metabolism letters, 2010-08, Vol.4 (3), p.139

2010

Link zum Volltext

Verfügbarkeit prüfen

LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice

European journal of heart failure, 2016-04, Vol.18 (4), p.386-393

2016

Link zum Volltext

Verfügbarkeit prüfen

A novel inducible cholesterol efflux peptide, FAMP, protects against myocardial ischemia reperfusion injury through a nitric oxide pathway

International journal of cardiology, 2016-01, Vol.202, p.810-816

2016

Link zum Volltext

Verfügbarkeit prüfen

Macrophage paraoxonase 2 regulates calcium homeostasis and cell survival under endoplasmic reticulum stress conditions and is sufficient to prevent the development of aggravated atherosclerosis in paraoxonase 2 deficiency/apoE−/− mice on a Western diet

Molecular genetics and metabolism, 2012-11, Vol.107 (3), p.416-427

2012

Link zum Volltext

Verfügbarkeit prüfen

Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels

Molecular genetics and metabolism, 2010-09, Vol.101 (1), p.66-75

2010

Link zum Volltext

Verfügbarkeit prüfen

Origin of histiocyte-like cells and multinucleated giant cells in malignant fibrous histiocytoma: Neoplastic or reactive?

Pathology international, 1999-01, Vol.49 (1), p.14-22

1999

Link zum Volltext

Verfügbarkeit prüfen

Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound

Journal of cardiology, 2007-10, Vol.50 (4), p.229-234

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1

Virchows Archiv : an international journal of pathology, 1998-11, Vol.433 (5), p.435-441

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaPeripheral Vascular Disease

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Rivaroxaban, a factor Xa inhibitor, induces the secondary prevention of cardiovascular events after myocardial ischemia reperfusion injury in mice

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes

HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]

Recent progress in molecular mechanisms of angiotensin II type 1 and 2 receptors

Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor

Chymase inhibitors

Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins

Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo

Differential Bonding Interactions of Inverse Agonists of Angiotensin II Type 1 Receptor in Stabilizing the Inactive State

FAMP, a Novel ApoA‐I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE‐Deficient Mice

The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways

Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects

Antiarrhythmogenic Effect of Reconstituted High-Density Lipoprotein Against Ischemia/Reperfusion in Rats

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma

L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice

LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice

A novel inducible cholesterol efflux peptide, FAMP, protects against myocardial ischemia reperfusion injury through a nitric oxide pathway

Macrophage paraoxonase 2 regulates calcium homeostasis and cell survival under endoplasmic reticulum stress conditions and is sufficient to prevent the development of aggravated atherosclerosis in paraoxonase 2 deficiency/apoE−/− mice on a Western diet

Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels

Origin of histiocyte-like cells and multinucleated giant cells in malignant fibrous histiocytoma: Neoplastic or reactive?

Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound

Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1

Aktive Filter

Suchergebnisse filtern